• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精细化护理对精神分裂症患者影响的评估。

Evaluation of the impact of refined nursing care on schizophrenia patients.

作者信息

Zhang Yuanling, Liang Wenbin, Gui Jiao

机构信息

Department of PICU2, Wudong Hospital of Wuhan, Wuhan, Hubei, China.

出版信息

Medicine (Baltimore). 2025 Jan 17;104(3):e40848. doi: 10.1097/MD.0000000000040848.

DOI:10.1097/MD.0000000000040848
PMID:39833068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11749742/
Abstract

This study evaluates the impact of refined nursing interventions on patients with schizophrenia, focusing on disease severity, cognitive function, medication adherence, quality of life, and medication-related complications. The aim is to provide evidence for enhancing future clinical treatments. From January 2022 to January 2024, 201 schizophrenia patients were enrolled based on specific inclusion and exclusion criteria. Patients were allocated into 2 groups using propensity score matching: an experimental group that received refined nursing care and a control group that received routine care. Outcome measures included Positive and Negative Syndrome Scale scores, cognitive assessments (Mini-Mental State Examination and Nurses' Observation Scale for Inpatient Evaluation), medication adherence, quality of life, relapse rates, and medication-related side effects. After propensity score matching, baseline characteristics of the experimental and control groups were comparable. Following nursing interventions, the experimental group demonstrated significant improvements in Positive and Negative Syndrome Scale scores, cognitive assessments (Mini-Mental State Examination and Nurses' Observation Scale for Inpatient Evaluation), medication adherence, and quality of life compared to the control group. The experimental group also showed lower relapse rates and fewer medication side effects, confirming the enhanced effectiveness of refined nursing interventions. Refined nursing care significantly improved disease outcomes, cognitive function, medication adherence, and quality of life in schizophrenia patients, while reducing relapse rates and medication-related complications, highlighting its clinical value in psychiatric care.

摘要

本研究评估了精细化护理干预对精神分裂症患者的影响,重点关注疾病严重程度、认知功能、药物依从性、生活质量和药物相关并发症。目的是为加强未来的临床治疗提供证据。2022年1月至2024年1月,根据特定的纳入和排除标准招募了201名精神分裂症患者。采用倾向得分匹配法将患者分为两组:接受精细化护理的实验组和接受常规护理的对照组。结局指标包括阳性和阴性症状量表评分、认知评估(简易精神状态检查表和住院患者护士观察量表)、药物依从性、生活质量、复发率和药物相关副作用。倾向得分匹配后,实验组和对照组的基线特征具有可比性。护理干预后,与对照组相比,实验组在阳性和阴性症状量表评分、认知评估(简易精神状态检查表和住院患者护士观察量表)、药物依从性和生活质量方面均有显著改善。实验组的复发率也较低,药物副作用较少,证实了精细化护理干预的有效性增强。精细化护理显著改善了精神分裂症患者的疾病结局、认知功能、药物依从性和生活质量,同时降低了复发率和药物相关并发症,突出了其在精神科护理中的临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/11749742/6b2953da6bbf/medi-104-e40848-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/11749742/6b2953da6bbf/medi-104-e40848-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb91/11749742/6b2953da6bbf/medi-104-e40848-g001.jpg

相似文献

1
Evaluation of the impact of refined nursing care on schizophrenia patients.精细化护理对精神分裂症患者影响的评估。
Medicine (Baltimore). 2025 Jan 17;104(3):e40848. doi: 10.1097/MD.0000000000040848.
2
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.针对对当前药物治疗反应不佳或不耐受的精神分裂症患者,开展传统抗精神病药物与新型非典型药物对比,以及新型非典型药物与氯氮平对比的随机对照试验。
Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165. doi: 10.3310/hta10170.
3
Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.与香港社区精神分裂症患者抗精神病药物依从性相关的因素:一项横断面研究。
Int J Ment Health Nurs. 2013 Feb;22(1):35-46. doi: 10.1111/j.1447-0349.2012.00830.x. Epub 2012 Jun 27.
4
Randomized controlled trial of the effects of nursing care based on a telephone intervention for medication adherence in schizophrenia.基于电话干预的护理对精神分裂症患者药物治疗依从性影响的随机对照试验
Perspect Psychiatr Care. 2020 Jan;56(1):63-71. doi: 10.1111/ppc.12376. Epub 2019 Mar 25.
5
Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.棕榈酸帕利哌酮与第二代口服抗精神病药物在药物依从性、副作用及生活质量方面的比较
J Clin Psychopharmacol. 2019 Jan/Feb;39(1):57-62. doi: 10.1097/JCP.0000000000000993.
6
A pilot study of barriers to medication adherence in schizophrenia.一项关于精神分裂症患者药物治疗依从性障碍的试点研究。
J Clin Psychiatry. 2004 Feb;65(2):211-6. doi: 10.4088/jcp.v65n0211.
7
Treatment adherence and insight in schizophrenia.精神分裂症的治疗依从性与自知力
Psychiatr Hung. 2015;30(1):18-26.
8
A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia.患者视角下药物副作用对服药依从性的影响:一项全国范围内横断面调查研究精神分裂症患者的结果。
BMC Psychiatry. 2012 Mar 20;12:20. doi: 10.1186/1471-244X-12-20.
9
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.阿立哌唑与社区治疗的精神分裂症患者护理标准对照的多中心、随机、自然主义、开放标签研究:阿立哌唑精神分裂症试验(STAR)研究
Eur Psychiatry. 2007 Oct;22(7):433-43. doi: 10.1016/j.eurpsy.2007.03.002. Epub 2007 Jun 7.
10
A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.一项旨在提高精神分裂症患者口服抗精神病药物依从性的同伴支持项目。
J Adv Nurs. 2014 Oct;70(10):2293-302. doi: 10.1111/jan.12382. Epub 2014 Mar 16.

本文引用的文献

1
The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial.依西酞普兰与舍曲林治疗脑卒中后抑郁的安全性和有效性:一项随机对照试验。
BMC Psychiatry. 2024 May 15;24(1):365. doi: 10.1186/s12888-024-05833-w.
2
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019.精神分裂症的发病率、患病率和全球负担——来自全球疾病负担(GBD)2019 的数据,包括批判性评估。
Mol Psychiatry. 2023 Dec;28(12):5319-5327. doi: 10.1038/s41380-023-02138-4. Epub 2023 Jul 27.
3
A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
一种简单评分可识别射血分数保留的心力衰竭患者转甲状腺素蛋白淀粉样心肌病的风险增加。
JAMA Cardiol. 2022 Oct 1;7(10):1036-1044. doi: 10.1001/jamacardio.2022.1781.
4
Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia.人类血浆的多组学研究揭示了精神分裂症中失调的炎症和加速衰老的分子特征。
Mol Psychiatry. 2022 Feb;27(2):1217-1225. doi: 10.1038/s41380-021-01339-z. Epub 2021 Nov 5.
5
Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [C]DASB.未服用抗精神病药物的精神分裂症患者自知力缺乏与前额叶5-羟色胺转运体可用性之间的关联:一项使用[C]DASB的高分辨率PET研究
Neuropsychiatr Dis Treat. 2021 Oct 21;17:3195-3203. doi: 10.2147/NDT.S336126. eCollection 2021.
6
A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study.中文版简易智力状态检查量表(MMSE)与蒙特利尔认知评估量表(MoCA)在中老年人群轻度认知障碍筛查中的比较:一项横断面研究。
BMC Psychiatry. 2021 Oct 4;21(1):485. doi: 10.1186/s12888-021-03495-6.
7
Development of an adapted Clinical Global Impression scale for use in Angelman syndrome.用于安格曼综合征的适应性临床总体印象量表的制定。
J Neurodev Disord. 2021 Jan 4;13(1):3. doi: 10.1186/s11689-020-09349-8.
8
The burden of disease in early schizophrenia - a systematic literature review.早期精神分裂症的疾病负担 - 系统文献回顾。
Curr Med Res Opin. 2021 Jan;37(1):109-121. doi: 10.1080/03007995.2020.1841618. Epub 2020 Nov 13.
9
Prevalence and Impact of Relapse in Patients With Schizophrenia.精神分裂症患者复发的患病率和影响。
J Clin Psychiatry. 2020 Mar 24;81(2):MS19053BR1C. doi: 10.4088/JCP.MS19053BR1C.
10
Propensity Score Matching: A Statistical Method.倾向得分匹配:一种统计方法。
Clin Spine Surg. 2020 Apr;33(3):120-122. doi: 10.1097/BSD.0000000000000932.